Use of 2-(hydroxyalkyl)-1H-benz[de]isoquinoline-1,3(2H)-diones as anti-allergy agents
US4006238A · kind A · utility
11Cited by
4References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 28, 1975 |
| Grant date | Feb 1, 1977 |
| Priority date | — |
| Expiry date | Aug 28, 1995 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of treating allergies with a pharmaceutical composition containing as the active ingredient a compound or mixture of compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from hydrogen, halogen, trifluoromethyl, lower alkyl, lower alkoxy, lower alkylthio, nitro, amino, or cyano; and A is a straight or branched chain alkylene of 1 to 8 carbons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.